Page 3 - Flipbook
P. 3
By the end of this presentation, participants
will be able to:
• Understand the latest data on adjuvant BEP
x 1 for stage I NSGCT
• Recognize the current literature regarding
the pros and cons of robotic RPLND
Learning • Understand the choices of adjuvant
chemotherapy after primary RPLND
Objectives • Know the outcomes of surveillance after
complete response after chemotherapy in
patients with metastatic NSGCT
• Understand the importance of long-term
mental health and survivorship issues, in men
with testicular cancer
• Know the future potential of miRNA as a
biomarker and the role of RPLND in
seminoma
